SCHEMBL497016

SCHEMBL497016

CCCCCCCCCCCS(=O)(=O)O

nearest known ligand 0.56

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
▸ FAAH O00519 5/20 0.56
▸ EPHX2 P34913 1/20 0.56
▸ CA2 P00918 4/20 0.50
▸ APP P05067 1/20 0.48
▸ CA1 P00915 2/20 0.46
▸ CES1 P23141 5/20 0.45
▸ CES2 O00748 2/20 0.45
▸ TSHR P16473 1/20 0.44
▸ THRB P10828 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL496699 1.00 FAAH (0.56) FAAHEPHX2CA2APPCA1
SCHEMBL151083 1.00 FAAH (0.56) FAAHEPHX2CA2APPCA1
SCHEMBL496726 1.00 FAAH (0.56) FAAHEPHX2CA2APPCA1
SCHEMBL437985 1.00 FAAH (0.56) FAAHEPHX2CA2APPCA1
SCHEMBL908021 1.00 FAAH (0.56) FAAHEPHX2CA2APPCA1
SCHEMBL304724 1.00 FAAH (0.56) FAAHEPHX2CA2APPCA1
SCHEMBL303808 1.00 FAAH (0.56) FAAHEPHX2CA2APPCA1
SCHEMBL1239006 1.00 FAAH (0.56) FAAHEPHX2CA2APPCA1
SCHEMBL22608765 1.00 FAAH (0.56) FAAHEPHX2CA2APPCA1
SCHEMBL150843 1.00 FAAH (0.56) FAAHEPHX2CA2APPCA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 460 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119662134-A Silicon wafer polishing composition and preparation process thereof 万华化学集团电子材料有限公司 2025-03-21 — — CN claimed
CN-119350205-A Synthesis method and application of diselenide coupling gemini sodium sulfonate compound 江南大学 2025-01-24 — — CN claimed
EP-3605097-B1 SUBSTANCE THAT PREVENTS ANTIGEN-ANTIBODY REACTION INHIBITION BY BODY FLUID NH FOODS LTD (JP) 2024-11-13 — — EP claimed
CN-118946594-A Ammonia-free latex composition 阿弗拉泰克斯技术有限责任公司 2024-11-12 — — CN claimed
CN-118223305-A Knitted fabric and preparation method thereof 海宁佳豪针织有限公司 2024-06-21 — — CN claimed
EP-4225882-A1 POST CMP CLEANING COMPOSITIONS Entegris, Inc. (US) 2023-08-16 — — EP claimed
WO-2022076265-A1 POST CMP CLEANING COMPOSITIONS ENTEGRIS, INC. (US) 2022-04-14 — — WO claimed
CN-113788793-A Sulfonic acid functionalized imidazole ionic liquid catalyst and preparation method and application thereof 南昌大学 2021-12-14 — — CN claimed
US-10937599-B2 Electrolytic capacitor PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD. (JP) 2021-03-02 — — US claimed
CN-112266377-A Dendrobium officinale Kimura et Migo extract analogue and preparation method and application thereof 云南农业大学 2021-01-26 — — CN claimed
WO-2018093864-A1 NANOPARTICLE CONJUGATES AND USES THEREOF MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2018-05-24 — — WO claimed
US-20130327651-A1 PLATING BATHS AND METHODS FOR ELECTROPLATING SELENIUM AND SELENIUM ALLOYS INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2013-12-12 — — US claimed
EP-2578577-A1 Sulfonyl esters of tetrahydrocannabinol and derivatives thereof Albany Molecular Research, Inc. (US) 2013-04-10 — — EP claimed
US-7674922-B2 Process for production of delta-9-tetrahydrocannabinol ALBANY MOLECULAR RESEARCH, INC. (US) 2010-03-09 — — US claimed
EP-1203063-B1 NATURAL GAS HYDRATE AND METHOD FOR PRODUCING SAME METASOURCE PTY LTD (AU) 2008-07-02 — — EP claimed
EP-1928853-A2 PROCESS FOR PRODUCTION OF DELTA-9-TETRAHYDROCANNABINOL AMR Technology, Inc. (US) 2008-06-11 — — EP claimed
US-20070093665-A1 Process for production of delta-9- tetrahydrocannabinol AMR TECHNOLOGY, INC. (US) 2007-04-26 — — US claimed
WO-2007041167-A2 PROCESS FOR PRODUCTION OF DELTA-9-TETRAHYDROCANNABINOL AMR TECHNOLOGY, INC. (US) 2007-04-12 — — WO claimed
US-12570689-B2 Purification of GLP-1 analogues BIOCON LIMITED (IN) 2026-03-10 — — US disclosed
US-3956252-A BASIC NITROGEN-CONTAINING SALT OF PHYTIC ACID SHOWA DENKU K.K. (JA) 1976-05-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12570689-B2 Purification of GLP-1 analogues GLP1R, GIPR, IAPP FAAH 362/4885EPHX2 3302/4885CA2 732/4885
US-20070093665-A1 Process for production of delta-9- tetrahydrocannabinol CNR2, CNR1, HRH4 FAAH 4/4885EPHX2 1062/4885CA2 920/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback